Characterizing the Contribution of the Group B Streptococcal Surface Adhesin BspC Interaction with Host Vimentin to Disease and Colonization

表征 B 族链球菌表面粘附素 BspC 与宿主波形蛋白相互作用对疾病和定植的贡献

基本信息

  • 批准号:
    10312484
  • 负责人:
  • 金额:
    $ 3.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Group B Streptococcus (GBS, also known as Streptococcus agalactiae) is a Gram-positive, -hemolytic bacterium normally found in the human gastrointestinal and urogenital tracts. GBS remains a leading cause of invasive disease in newborns and certain adult populations including pregnant women. The development of GBS disease is initiated by the asymptomatic colonization of the female genital tract and during pregnancy can be associated with chorioamnionitis, puerperal endometritis and preterm labor. Approximately 20-30% of healthy women are colonized rectovaginally with GBS; the majority of infants born to these women will themselves become colonized with the bacterium. Newborn infection also results from ascending infection of the bacterium through the placental membranes to initiate infection in utero. GBS is the principle etiologic agent of neonatal bacterial meningitis, and GBS meningeal infection results in 10-15% mortality despite antibiotic treatment. Additionally, up to 40% of survivors develop permanent neurological sequelae, including cognitive defects, seizure activity, and cerebral ischemia. To access the central nervous system (CNS) and cause meningitis blood-borne GBS must penetrate the blood-brain barrier (BBB); however, little is known about the very first and crucial interaction between GBS and the BBB that initiates bacterial crossing and disease progression. This proposal seeks to characterize the role of a newly identified GBS Antigen I/II family adhesin, BspC, to the pathogenesis of colonization and CNS disease. We have recently determined that BspC promotes attachment to BBB endothelium and contributes to the development of GBS meningitis. Further we have discovered that BspC interacts directly with vimentin, a widely distributed intermediate filament protein found in blood vessel endothelial cells. Thisproposal seeks toidentify the region on BspC that interacts with vimentin, and to characterize the role of this interaction in GBS meningitis and colonization of the female reproductive tract. I hypothesize that the binding region is contained within the globular variable domain (V- domain) of BspC and contributes to both GBS meningitis and vaginal colonization/ascending infection. These hypotheses will be addressed with both in vitro and in vivo models of BBB penetration and vaginal colonization in the following specific aims: Aim 1: Identify the critical regions and amino acids required for BspC V-domain- vimentin interaction; Aim 2: Characterize the role of BspC and vimentin in the female reproductive tract. These data will clarify the crucial role of Antigen I/II proteins to GBS colonization and disease and provide fundamental mechanistic insights that may inform new treatment strategies to prevent colonization and ultimately bacterial meningitis.
项目概要 B 族链球菌(GBS,也称为无乳链球菌)是一种革兰氏阳性、-溶血性链球菌 通常存在于人类胃肠道和泌尿生殖道中的细菌。 GBS 仍然是导致 新生儿和某些成年人(包括孕妇)的侵袭性疾病。的发展 GBS 疾病是由女性生殖道的无症状定植引发的,在怀孕期间可以 与绒毛膜羊膜炎、产后子宫内膜炎和早产有关。大约20-30% 健康女性的直肠阴道内有 GBS 定植;这些妇女所生的大多数婴儿将 它们本身就被细菌定殖。新生儿感染也由上行感染引起 细菌通过胎盘膜在子宫内引发感染。 GBS是主要病因 新生儿细菌性脑膜炎的病原体,GBS 脑膜感染导致 10-15% 的死亡率,尽管 抗生素治疗。此外,高达 40% 的幸存者会出现永久性神经系统后遗症,包括 认知缺陷、癫痫发作和脑缺血。进入中枢神经系统(CNS)并 引起脑膜炎的血源性GBS必须穿透血脑屏障(BBB);然而,人们对此知之甚少 GBS 和 BBB 之间最初也是最重要的相互作用,引发细菌交叉和疾病 进展。该提案旨在描述新鉴定的 GBS 抗原 I/II 家族粘附素的作用, BspC,定植和中枢神经系统疾病的发病机制。我们最近确定 BspC 促进 BBB 内皮的附着并促进 GBS 脑膜炎的发展。进一步我们 发现 BspC 直接与波形蛋白相互作用,波形蛋白是一种广泛分布的中间丝蛋白 存在于血管内皮细胞中。该提案旨在确定 BspC 上与 波形蛋白,并描述这种相互作用在 GBS 脑膜炎和女性定植中的作用 生殖道。我假设结合区域包含在球状可变域(V- BspC 的结构域),并导致 GBS 脑膜炎和阴道定植/上行感染。这些 将通过 BBB 渗透和阴道定植的体外和体内模型来解决假设 目标 1:确定 BspC V 结构域所需的关键区域和氨基酸 波形蛋白相互作用;目标 2:表征 BspC 和波形蛋白在女性生殖道中的作用。这些 数据将阐明抗原 I/II 蛋白对 GBS 定植和疾病的关键作用,并提供 基本的机制见解可以为防止定植和预防新的治疗策略提供信息 最终导致细菌性脑膜炎。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Haider Syed Manzer其他文献

Haider Syed Manzer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 3.4万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 3.4万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 3.4万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 3.4万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 3.4万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 3.4万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 3.4万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 3.4万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 3.4万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 3.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了